-
The CHS attends Newfoundland and Labrador Family Camp 2022
by Wendy Quinn, President of the Canadian Hemophilia Society This summer I had the great privilege of finally attending the infamous Camp Blast – the Newfoundland and Labrador’s version...
No change to factor IX product mix in Quebec
Montreal, August 15, 2022 – On July 15, Héma-Québec announced the results of the recombinant factor IX tender for the period from October 1, 2022 to March 31, 2025....
2022 James Kreppner Memorial Scholarship and Bursary Program recipients
In an effort to bring young volunteers into the CHS, and in recognition that a sound education is of utmost importance particularly for those who might not be able...
Important CHS survey on gene therapy
Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best represent people with hemophilia...
INNOVATORS
BUILDER
Believers
